Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial. - Wikidata - wikimedia - TriplyDB

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.

http://www.wikidata.org/entity/Q43265559

about

Non-alcoholic fatty liver disease: what the clinician needs to know.A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence The therapy of insulin resistance in other diseases besides type 2 diabetes The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review Non-alcoholic fatty liver disease: what has changed in the treatment since the beginning?Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment Treatment of nonalcoholic steatohepatitis in adults: present and future Nonalcoholic fatty liver disease: new treatments Hepatic steatosis and Type 2 diabetes: current and future treatment considerations.Metformin and metabolic diseases: a focus on hepatic aspects Systematic review: Preventive and therapeutic applications of metformin in liver disease Treatment of nonalcoholic fatty liver disease: role of AMPK.Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Practice patterns in NAFLD and NASH: real life differs from published guidelines Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease Inflammatory mediators of hepatic steatosis.Molecular pathways in non-alcoholic fatty liver disease.Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes.Nonalcoholic Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective.Review article: the management of paediatric nonalcoholic fatty liver disease.Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease.The role of insulin-sensitizing agents in the treatment of nonalcoholic steatohepatitis.Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome.The role of metformin in the management of NAFLD Effect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical Trial An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD).Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease.Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver.KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Clinical approaches to non-alcoholic fatty liver disease Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.Current therapeutic strategies in non-alcoholic fatty liver disease.Expert opinion on current therapies for nonalcoholic fatty liver disease.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

P2860

Q24563068-857AB638-0383-4AD3-B373-471A207CCC63 Q26744488-5D8B3392-1C22-4DB9-AB1F-17713CEEDBCE Q26822399-BEA99ED0-9D77-4388-A4CC-924401D566EE Q26825269-97B2E63C-CE2B-41FC-9F09-756BE9D566BA Q26829503-85630822-C453-4567-91A3-7D1B1DD0B695 Q26852019-1E735BE8-9AEC-4D8C-A77D-40C530E8A0BC Q26852403-63115573-14E3-4425-8BEC-28E5D2EA366F Q27021161-04BB9E84-6BE8-4C03-B99F-129D60F31B89 Q27691399-26843787-5E9F-45B5-B272-376E0A995C40 Q28082736-3A6EB947-D3C7-4D26-9D37-B8091784D1A2 Q28085535-334D2641-2EC7-49E0-B6DB-17E148E8E901 Q30248230-DF6C8FCD-42C5-4BA4-81C6-52B47F7529F9 Q30248535-5D4D89DF-D62F-4708-885F-0879BC8B1181 Q30277747-8211D4C6-54F2-4D0F-B665-7C7AEDD7F2B5 Q30389752-A55A4813-6441-4688-9986-79CB16F5995A Q33563877-09D16803-5E44-4F46-BAD0-2683BD3BD906 Q33734136-05ABE2AC-4306-4DDE-A6D7-3F25A98B34B5 Q33890230-8AA31852-D3F8-4AFC-A524-6FA0AC4CFC84 Q33932461-AD7F7CCC-9ED6-4EB7-BDF5-B5A07F8FEC04 Q34412650-4F0D1EC0-AB76-496D-AF20-DED15B6ADB21 Q34440962-20AEC5E6-E3B3-4462-AF19-D7B9B2DD1A4E Q34449857-2611F0E0-7B0E-4EAE-8BA9-F83DF65F6AE3 Q34921969-7DF8911D-0058-42F2-B2AA-28BD3F7AB279 Q35090416-4CE91AEA-B29D-49B7-8BF9-5C8CF4B36473 Q35250192-3260DED5-3520-4635-A1E4-C954F8FECBAC Q35614956-6F344A01-4328-4722-9CD9-9B208E108E23 Q35639142-2B914DED-54F8-4C44-9A17-64F54C818233 Q36328050-7EC9966A-D393-4D51-8938-E8A8BE97FEB9 Q36470320-66049958-85D3-40DB-B61A-E163E6B3D26A Q36503839-7197E4C1-1CC5-4C45-BB22-7BC90FCF661E Q36791363-A0D74280-A54D-496C-988C-97E483E4365A Q37069302-A7911991-22A8-484B-867D-1678A61BDA98 Q37375539-11A8D9FC-3B29-443E-BE3E-E00FDC528151 Q37438847-699C1698-479B-4BA3-9947-53BD0F4E4FB0 Q37488800-106BF91C-FB13-4F05-9AF0-F0D6F4BDB846 Q37596187-32E52EDA-0155-4B53-80B0-853DF90B1BE4 Q37613264-11FEF12C-CD94-41F5-A643-C7E662A3E7FE Q37859419-74D1CB64-2C6B-48A8-982B-A4D3FDC9D584 Q37884620-B7376718-14B0-4B9C-A464-DC6BA4EC63FD Q37978785-0926477C-2AD4-4D6A-82E1-63AB41063CAE

P2860

Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.

http://www.wikidata.org/entity/Q43265559

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Metformin in patients with non ...... randomized, controlled trial.

@en

Metformin in patients with non ...... randomized, controlled trial.

@nl

type

label

Metformin in patients with non ...... randomized, controlled trial.

@en

Metformin in patients with non ...... randomized, controlled trial.

@nl

prefLabel

Metformin in patients with non ...... randomized, controlled trial.

@en

Metformin in patients with non ...... randomized, controlled trial.

@nl

P1433

Q43265559-AD225858-47A7-43CC-A38C-188FA41F574B

P1476

Q43265559-D81EEAD4-E9DB-4758-AAFF-8F9CB18950BB

P2093

Q43265559-17E03708-FEB7-4876-BFCE-D9AB58FD79D3

Q43265559-3C450197-1657-4158-AFC3-8900C5C2CBD3

Q43265559-70945AC9-2100-4EE4-B816-2226731F89C4

Q43265559-8B07E81C-72F4-45E3-BCF5-30AC1CADF8FB

Q43265559-99AD3B46-7836-47DD-90CF-35E9A32740AC

Q43265559-A309BDB8-7EA8-4CE3-B23B-BB99BE46F780

Q43265559-BA14EE5F-A32F-4175-B0C9-6A74BE02DDE6

Q43265559-D580345F-345B-44AF-A50F-2F77CC09968E

Q43265559-EB2404E9-3AF9-4FE2-9C4B-DCD3629641FE

P2860

Q43265559-025859DA-C7B6-4923-B2F5-19896D37A22A

Q43265559-0972290F-86AF-4E80-A08F-BDF5FF26805B

Q43265559-159F42F3-13D7-4F2D-8C5F-B9F7DDAC201A

Q43265559-1B972809-13BC-49C5-9E07-ACF50026043E

Q43265559-20F355C4-CBF0-44D1-8E86-FAB1E1EDBF7D

Q43265559-30BC7452-0FBD-47FA-849A-3280149BA4BA

Q43265559-6851D192-4683-408B-A08B-D7278FD1EF47

Q43265559-698DA979-6DFD-4D1B-B4DA-1CF41F4B0C71

Q43265559-6DF1851C-F58D-4680-AFC6-BF2A43CD4426

Q43265559-752F3E58-7FEE-4AC6-A1EA-59E88369E7E2

P304

Q43265559-BEDC42B8-DB7E-483D-A95F-7FC4E5973B89

P31

Q43265559-8DCAC254-63A4-4112-8267-6A7CB87F687C

P356

Q43265559-4BF63A99-31F2-4A21-9A36-B17E0ADB0573

P433

Q43265559-80FEAAE1-8962-4650-9067-6D5E9AAE02A8

P478

Q43265559-5792E6A7-EA4F-4A25-BD74-5A7ACDF3F247

P577

Q43265559-96063E9B-D002-4AB8-846D-76368B491338

P5875

Q43265559-1FF0E8CE-CFA8-427E-9CE2-865A4DDEF4F2

P698

Q43265559-F38EA87A-8C8F-4F6F-BAC9-0C606C6FEFC3

P921

Q43265559-282F82CA-767F-4A96-BF4D-492DA7C3EADD

P356

00365520902845268

P1433

Scandinavian Journal of Gastroenterology

P1476

Metformin in patients with non ...... randomized, controlled trial.

@en

P2093

Else Marit Løberg

http://www.w3.org/2001/XMLSchema#string

Gabriele Raschpichler

http://www.w3.org/2001/XMLSchema#string

Heidi Beate Eggesbø

http://www.w3.org/2001/XMLSchema#string

Hilde Løland von Volkmann

http://www.w3.org/2001/XMLSchema#string

John Willy Haukeland

http://www.w3.org/2001/XMLSchema#string

Kristian Bjøro

http://www.w3.org/2001/XMLSchema#string

Kåre Birkeland

http://www.w3.org/2001/XMLSchema#string

Terese Haaland

http://www.w3.org/2001/XMLSchema#string

Zbigniew Konopski

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin: new understandings, new uses.

Role of AMP-activated protein kinase in mechanism of metformin action

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

Metformin and body weight

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Nonalcoholic fatty liver disease

Long-term follow-up of patients with NAFLD and elevated liver enzymes

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review.

P304

853-860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365520902845268

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26878221

http://www.w3.org/2001/XMLSchema#string

P698

19811343

http://www.w3.org/2001/XMLSchema#string

P921